The North American hematology market is poised to grow substantially due to new breakthroughs in areas like stem cell research, genetic therapies, hemoglobinopathies, proteomics, pharmacogenomics, and bleeding disorders in the coming years.
Similarly, factors like the consolidation of diagnostic laboratory chains and the increase in public awareness are driving the growth of the hematology market. The emerging countries are expected to outperform the U.S. and European countries. This is mainly due to the increase in major hospital chains opening new centers in major cities, as well as an increase in government expenditure being used to purchase automated hematological analyzers and reagents.
Hematological tests require a lot of mixing and agitation which is difficult to do manually. Hence, automatic mixing and agitation can be conducted with the help of these instruments. Hematology equipment also includes software that helps in making the data entry task easier. For example, Beckman Coulter’s UniCel DxH Slidemaker Stainer Cellular Analysis System provides the most advanced slide-making technology with lean efficiency. This technology has a load-and-go feature which makes slide making very easy. It is supported by the DxH SMS software that provides thermal printing technology and 2D barcode scanning that helps to increase the overall productivity of laboratories. Thus, automation is the biggest factor driving the growth of the hematology market as it helps in the reduction of cost, time, and labor.
The Centers for Medicare & Medicaid Services (CMS) has estimated that healthcare spending in the U.S. is expected to grow from $2.7 trillion in 2011 to about $4.6 trillion in 2018, at a CAGR of 6.8% for the given period. Similarly, in emerging countries, awareness and an increasing middle-class population, with a more disposable income to spend on healthcare, will be a driving force for the growth of this market.
The report 'North American Hematology Market forecast for 2018' analyzes the market by segments such as reagents and instruments.
North America commanded the largest share of 41.75% of the global hematology market at $1810.4 million in 2013, and is expected to reach $2479.05 million by 2018, at a CAGR of 6% from 2013 to 2018.
In North America hematology market, the U.S. holds the largest share of 89%, at $1609.2 million in 2013, and is expected to reach $2200.4 million by 2018, at a CAGR of 6%, for the given period.
The report also provides an extensive competitive landscaping of companies operating in this market. The main companies operating in hematology market and extensively covered in this report are Abbott Laboratories, Inc., Beckman Coulter, CellaVision, HemoCue, Horiba, Siemens Healthcare, and Sysmex Corporation.
Segment and country-specific company shares, news & deals, mergers and acquisitions, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in the report.
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
- Unmet needs, revenue pockets, and potential areas for expansion hematology market
- Comprehensive review of key suppliers of analyzers, POC, and slide and imaging manufacturers
Extensive Market Data
- CBC count test volumes
- Analyzer market by client segments
- Analyzers revenue breakdown
- Digital imaging market share
Current and Emerging Products
- Analysis of current and emerging hematology and immunodiagnostic tests
- Review of current instrumentation technologies in hematology, and feature,comparison
of high, medium, and low-volume/POC analyzers
- Usage pattern (in-depth trend analysis) of products (segment wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment wise and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virility and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Alternative Products: Impact analysis
MMM’s healthcare decision making quadrant is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure).
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
North America In Vitro Diagnostics
In 2013, the Americas had the largest market, a 42% share of the Global IVD market, followed by Europe with a 31% share. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of IVD tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets. The report “North American In Vitro Diagnostics Market forecast for 2018 “analyzes the market by 5 segments such as reagents, instruments, techniques, applications and end-users.
Europe In Vitro Diagnostics
In 2013, the Americas had the largest market, a 42% share of the European IVD market, followed by Europe with a 31% share. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of IVD tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets. The report “European In Vitro Diagnostics Market forecast for 2018 “analyzes the market by 5 segments such as reagents, instruments, techniques, applications and end-users. Germany commanded the largest share in European IVD market.
Asia In Vitro Diagnostics
Asian IVD market is growing in double digit and will continue to grow in future. China commanded the largest share in Asian IVD market. The report “Asian In Vitro Diagnostics Market forecast for 2018 “analyzes the market by 5 segments such as reagents, instruments, techniques, applications and end-users.